Sahin Senay

Dr. Sahin Senay


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
SSSahin Senay
Sahin Senay
CAC. Alhan
C. Alhan
FTF. Toraman
F. Toraman
HKH. Karabulut
H. Karabulut
SDS. Dagdelen
S. Dagdelen
HCH. Cagil
H. Cagil

5 January 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
AGAhmet Ü. Güllü
Ahmet Ü. Güllü
SSSahin Senay
Sahin Senay
MKMuharrem Kocyigit
Muharrem Kocyigit
EZErtugrul Zencirci
Ertugrul Zencirci
AAAhmet Akyol
Ahmet Akyol
CACem Alhan
Cem Alhan

18 September 2008 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
SSSahin Senay
Sahin Senay
FTFevzi Toraman
Fevzi Toraman
SGSerdar Gunaydin
Serdar Gunaydin
MKMeltem Kilercik
Meltem Kilercik
HKHasan Karabulut
Hasan Karabulut
CACem Alhan
Cem Alhan
Objective: This study is designed to determine and compare the effects of transfusion and coated circuits on the inflammatory response during cardiop

1 January 2017 in Annals of Cardiothoracic Surgery
Verified
Journal Article
Closed access
PDF file
SSSahin Senay
Sahin Senay
AGAhmet Umit Gullu
Ahmet Umit Gullu
CACem Alhan
Cem Alhan
Robotic mitral valve replacement for rheumatic mitral disease

1 November 2009 in Perfusion
Verified
Journal Article
Closed access
PDF file
SSSahin Senay
Sahin Senay
FTFevzi Toraman
Fevzi Toraman
HKHasan Karabulut
Hasan Karabulut
CACem Alhan
Cem Alhan
Background and objective: Low hematocrit level and transfusion may coexist during cardiopulmonary bypass and the actual impact of one on the outcome parameters may be counfounded or masked by the other. This study aims to determine the impact of the lowest hematocrit level during cardiopulmonary bypass on outcome parameters in non-transfused patients. Methods: Two thousand six hundred and thirty-two consecutive patients who underwent isolated coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass were evaluated prospectively:1854 (70.4%) patients who did not receive any red blood cells during hospital stay were included in the study. Perioperative data and outcome parameters were recorded. Outcomes were evaluated in 2 groups according to the lowest level of hematocrit (>21%: high hematocrit group, n= 1680, (91.6%) and ≤21%: low hematocrit group, n=174, (9.4%)) during cardiopulmonary bypass. Results: Overall mean lowest hematocrit level of patients was 27.7±4.4% (19.7±1.9% in the low hematocrit group, 28.5±4.1% in the high hematocrit group). The comparison of outcome parameters regarding the time on ventilator, duration of intensive care unit stay, intensive care unit re-admission, hospital re-admission, reoperation for bleeding or tamponade, low cardiac output, postoperative atrial fibrillation, stroke, creatinine level at hospital discharge, new onset renal failure, mediastinitis, pulmonary complication and mortality rates were similar in both groups. Conclusions: Our findings suggest that a lowest hematocrit level of ≤21% during cardiopulmonary bypass has no adverse impact on outcome after isolated coronary surgery in non-transfused patients.

12 June 2013 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
LKLeyla Kılıç
Leyla Kılıç
SSSahin Senay
Sahin Senay
AGA. Ümit Güllü
A. Ümit Güllü
CACem Alhan
Cem Alhan
The longer durations of cardiopulmonary bypass and aortic cross-clamp times remain the disadvantages of robotic or minimally invasive cardiac surgery. For this reason, every small contribution to speeding up these procedures is of the utmost importance. Here, we present a practical, easy and time-saving suture technique for atrial closure. It consists of a hand-made loop at one end of the suture and saves the time otherwise consumed by knotting. It may also be used during conventional or minimally invasive cardiac surgery.